Embark logo

Embark Veterinary, Inc.

Consumer Products & Services

Embark Stock

Embark Veterinary, Inc. provides dog DNA testing to uncover breed identification, genetic health risks, and traits. Their tests cover hundreds of breeds and genetic conditions, offering comprehensive insights into a dog's ancestry and health. This information aids pet owners, breeders, and veterinarians in making informed decisions about canine care, nutrition, and preventive health measures. Embark also supports veterinary practices with specialized tools and resources to enhance patient care and treatment.

Founded: 2015

Embark Website

Embark Company Overview

Embark Veterinary, Inc. is a leading provider of dog DNA testing services, offering a range of products designed to uncover detailed genetic information about dogs. The company’s mission is to improve canine health and wellness by providing pet owners, breeders, and veterinarians with actionable insights. Embark’s comprehensive DNA tests analyze a dog’s genetic makeup to identify breed composition, screen for potential health risks, and determine various traits. Their product line includes the Breed + Health Kit, which tests for hundreds of breeds and screens for hundreds of genetic health conditions, ensuring thorough and accurate results. The company is known for its scientific rigor and extensive database, which enhances the precision and reliability of its testing. Pet owners can use Embark’s tests to gain a deeper understanding of their dog’s ancestry, uncover potential genetic health issues early, and make informed decisions about their pet’s diet, lifestyle, and preventive care. Additionally, Embark’s platform allows users to discover and connect with their dog’s relatives, fostering a sense of community among dog owners. For breeders, Embark provides essential tools to ensure the health and vitality of their breeding lines. The genetic information obtained from Embark’s tests helps breeders make informed breeding decisions, reducing the risk of inherited health conditions and improving the overall quality of their breeding programs. Veterinarians also benefit from Embark’s services, gaining access to detailed genetic profiles that can aid in diagnosis and treatment planning. Embark offers specialized resources and support to veterinary practices, enhancing the level of care provided to canine patients. Embark is committed to advancing canine health through continuous research and development. The company collaborates with academic institutions, veterinary professionals, and industry experts to stay at the forefront of genetic research. By leveraging the latest scientific advancements, Embark aims to provide the most accurate and comprehensive genetic testing available. Their dedication to quality and innovation has made them a trusted name in the field of canine genetics, helping to improve the lives of dogs and their owners worldwide.

Management Team

Ryan Boyko Ph.D Co-Founder, CEO
Amish Desai CFO
Matt Barton CTO
Emily Levada CPO

Funding Information